Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.8T | 8.4T | 7.9T | 8.0T |
| Cost of revenue | 5.2T | 4.9T | 4.9T | 4.8T |
| Gross profit | 3.7T | 3.4T | 3.1T | 3.1T |
| Operating expense | ||||
| Research & development | 103.5B | 154.1B | 101.9B | 125.6B |
| Selling general and admin | 1.3T | 1.2T | 1.3T | 1.1T |
| Other operating expenses | 117.5B | 335.2B | 167.9B | 165.8B |
| Operating income | 1.4T | 1.1T | 700.5B | 1.1T |
| Non operating interest income | ||||
| Income | 50.4B | 49.7B | 53.9B | 35.3B |
| Expense | 9.4B | 15.4B | 9.1B | 19.4B |
| Other income expense | — | — | — | — |
| Pretax income | 1.4T | 1.1T | 724.6B | 1.1T |
| Tax provision | 318.8B | 276.6B | 159.1B | 256.6B |
| Net income | 1.1T | 850.2B | 565.5B | 843.2B |
| Basic EPS | 23.6 | — | — | — |
| Diluted EPS | 23.6 | — | — | — |
| Basic average shares | 45.7B | — | — | — |
| Diluted average shares | 45.7B | — | — | — |
| EBITDA | 1.5T | 1.2T | 825.4B | 1.2T |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -33.7B | 12.0B | 7.8B | 4.3B |
| Preferred stock dividends | 0 | 0 | 0 | 0 |